Cargando…
Benefit of cabazitaxel in previously treated metastatic castration-resistant prostate cancer; CARD trial
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759182/ https://www.ncbi.nlm.nih.gov/pubmed/33376276 http://dx.doi.org/10.4103/iju.IJU_160_20 |
| _version_ | 1783627077406162944 |
|---|---|
| author | Mishra, Ankit |
| author_facet | Mishra, Ankit |
| author_sort | Mishra, Ankit |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7759182 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77591822020-12-28 Benefit of cabazitaxel in previously treated metastatic castration-resistant prostate cancer; CARD trial Mishra, Ankit Indian J Urol Uroscan Wolters Kluwer - Medknow 2020 2020-10-01 /pmc/articles/PMC7759182/ /pubmed/33376276 http://dx.doi.org/10.4103/iju.IJU_160_20 Text en Copyright: © 2020 Indian Journal of Urology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Uroscan Mishra, Ankit Benefit of cabazitaxel in previously treated metastatic castration-resistant prostate cancer; CARD trial |
| title | Benefit of cabazitaxel in previously treated metastatic castration-resistant prostate cancer; CARD trial |
| title_full | Benefit of cabazitaxel in previously treated metastatic castration-resistant prostate cancer; CARD trial |
| title_fullStr | Benefit of cabazitaxel in previously treated metastatic castration-resistant prostate cancer; CARD trial |
| title_full_unstemmed | Benefit of cabazitaxel in previously treated metastatic castration-resistant prostate cancer; CARD trial |
| title_short | Benefit of cabazitaxel in previously treated metastatic castration-resistant prostate cancer; CARD trial |
| title_sort | benefit of cabazitaxel in previously treated metastatic castration-resistant prostate cancer; card trial |
| topic | Uroscan |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759182/ https://www.ncbi.nlm.nih.gov/pubmed/33376276 http://dx.doi.org/10.4103/iju.IJU_160_20 |
| work_keys_str_mv | AT mishraankit benefitofcabazitaxelinpreviouslytreatedmetastaticcastrationresistantprostatecancercardtrial |